These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 19644463)
1. Public-private partnership tackles TB challenges in parallel. Webb S Nat Rev Drug Discov; 2009 Aug; 8(8):599-600. PubMed ID: 19644463 [TBL] [Abstract][Full Text] [Related]
2. Bedaquiline (Sirturo) for multidrug-resistant tuberculosis. Med Lett Drugs Ther; 2013 Aug; 55(1423):66-8. PubMed ID: 23959388 [No Abstract] [Full Text] [Related]
3. Microbiology. TB--a new target, a new drug. Cole ST; Alzari PM Science; 2005 Jan; 307(5707):214-5. PubMed ID: 15653490 [No Abstract] [Full Text] [Related]
4. TMC207: the first compound of a new class of potent anti-tuberculosis drugs. Matteelli A; Carvalho AC; Dooley KE; Kritski A Future Microbiol; 2010 Jun; 5(6):849-58. PubMed ID: 20521931 [TBL] [Abstract][Full Text] [Related]
5. Race heats up for first-to-market drugs for resistant tuberculosis. Willyard C Nat Med; 2012 Aug; 18(8):1157. PubMed ID: 22869168 [No Abstract] [Full Text] [Related]
6. New drugs and regimens for treatment of TB. Leibert E; Rom WN Expert Rev Anti Infect Ther; 2010 Jul; 8(7):801-13. PubMed ID: 20586565 [TBL] [Abstract][Full Text] [Related]
7. MDR-TB has new drug foe after fast-track approval. Voelker R JAMA; 2013 Feb; 309(5):430. PubMed ID: 23385248 [No Abstract] [Full Text] [Related]
8. Shortening the treatment of tuberculosis. Mitchison DA Nat Biotechnol; 2005 Feb; 23(2):187-8. PubMed ID: 15696148 [No Abstract] [Full Text] [Related]
9. Trench warfare in a battle with TB. Marshall E Science; 2008 Jul; 321(5887):362-4. PubMed ID: 18635790 [No Abstract] [Full Text] [Related]
10. Unorthodox approach to the development of a new antituberculosis therapy. Barry CE N Engl J Med; 2009 Jun; 360(23):2466-7. PubMed ID: 19494223 [No Abstract] [Full Text] [Related]
11. Approval of a tuberculosis drug based on a paradoxical surrogate measure. Avorn J JAMA; 2013 Apr; 309(13):1349-50. PubMed ID: 23430122 [No Abstract] [Full Text] [Related]
12. New antituberculous drugs in development. Lalloo UG; Ambaram A Curr HIV/AIDS Rep; 2010 Aug; 7(3):143-51. PubMed ID: 20559756 [TBL] [Abstract][Full Text] [Related]
16. Synthesis and bioactivity of antitubercular peptides and peptidomimetics: an update. De Leon Rodriguez LM; Kaur H; Brimble MA Org Biomol Chem; 2016 Jan; 14(4):1177-87. PubMed ID: 26645944 [TBL] [Abstract][Full Text] [Related]
17. Molecule of the Month. TMC-207. Drug News Perspect; 2009 Sep; 22(7):421. PubMed ID: 19890499 [No Abstract] [Full Text] [Related]
18. Tuberculosis Drug Development: History and Evolution of the Mechanism-Based Paradigm. Chakraborty S; Rhee KY Cold Spring Harb Perspect Med; 2015 Apr; 5(8):a021147. PubMed ID: 25877396 [TBL] [Abstract][Full Text] [Related]
20. An update on the chemistry and medicinal chemistry of novel antimycobacterial compounds. Branco FS; Pinto AC; Boechat N Curr Top Med Chem; 2013; 13(22):2808-49. PubMed ID: 24111907 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]